This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

After an incubation period of around ten days (range 7 to 18 days) (1), clinical features develop as follows:

Catarrhal stage:

  • prodromal illness (lasts 2-4 days) with fever, coryza, conjunctivitis, and cough
  • Koplik spots -
    • pathognomonic for measles
    • bright red spots with a bluish white speck at the centre is seen on the buccal mucosa, especially on the inside of the cheeks
    • usually appears just before the onset of rash and continue for 2 or 3 days (3)
  • sometimes generalised lymphadenopathy
  • irritability
  • infective from onset
  • photophobia
  • sore throat
  • abdominal pain (3)

Exanthematous stage:

  • rash appears 3 to 5 days later, maculopapular, firstly behind the ears,spreads to the face, then down the body, becoming confluent, fading by the third day
  • severity of other symptoms may increase 2 – 4 days before the onset of the rash with the symptoms being most severe on the first day of rash (3)

Clinical recovery in uncomplicated measles may be seen shortly after the emergence of the rash (2).

In immunocompromised patients fever or rash may not be present for weeks or months after exposure (2).

Click here for an image of measles rash

The time frame for measles infection has been described (4):

 

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.